Clinical Trial Update: Evaluating Central Line Hub Contamination Using a Novel Capping Device [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/Phase 2 study evaluating a novel central line hub capping device to prevent hub contamination and catheter-relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Snippet

Sponsor: Endeavor Health | Conditions: Catheter-related Bloodstream Infection Due to Central Venous Catheter | Phase 1, Phase 2 | Status: UNKNOWN